Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 0.79
- Piotroski Score 6.00
- Grade Buy
- Symbol (EBS)
- Company Emergent BioSolutions Inc.
- Price $9.48
- Changes Percentage (0.8%)
- Change $0.08
- Day Low $9.37
- Day High $9.67
- Year High $15.10
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging health crises and acute/emergency care. It offers BioThrax, an anthrax vaccine; ACAM2000, a smallpox vaccine; Botulism Antitoxin Heptavalent to treat botulinum disease; vaccinia immune globulin intravenous that addresses complications from smallpox vaccine; raxibacumab for the treatment and prophylaxis of inhalational anthrax; Anthrasil to for inhalational anthrax; reactive skin decontamination lotion kits; and Trobigard, a combination drug-device auto injector product candidate; and Trobigard, a combination drug-device auto injector product candidate. The company also provides NARCAN, a nasal spray for the emergency treatment of known or suspected opioid overdose; Vivotif, an oral vaccine for typhoid fever; and Vaxchora, a single-dose oral vaccine to treat cholera. In addition, it is developing AP003, a Naloxone multidose nasal spray; AP007, a sustained release Nalmefene injection for treatment of opioid use disorder; AV7909, an anthrax vaccine; CGRD-001, a pralidoxime chloride/atropine auto-injector; CHIKV VLP, a chikungunya virus VLP vaccine; COVID-HIG for the treatment of SARS-CoV2; EGRD-001, a diazepam auto-injector; SIAN, an antidote for the initial treatment of acute poisoning of cyanide; and UniFlu, a universal influenza vaccine. Further, the company provides contract development and manufacturing services comprising drug substance and product manufacturing, and packaging, as well as technology transfer, process, and analytical development services. The company was incorporated in 1998 and is headquartered in Gaithersburg, Maryland.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/20/2025
- Fiscal Year End N/A
- Average Stock Price Target $51.50
- High Stock Price Target $65.00
- Low Stock Price Target $38.00
- Potential Upside/Downside N/A
- Consensus Rating Buy
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$10.97
- Trailing P/E Ratio -0.56
- Forward P/E Ratio -0.56
- P/E Growth -0.56
- Net Income $-760,500,000
Income Statement
Quarterly
Annual
Latest News of EBS
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
New Chrome, Safari, Firefox, Edge Warning -- Do Not Shop On These Websites
Web users are cautioned about a new threat campaign targeting holiday shoppers with fake websites that steal personal and financial data. The scammers are using tactics like phishing and typosquatting...
By Forbes | 5 days ago -
Is Bluesky down? Users turn away from Elon Musk's X, cause website outage
Following a surge in users leaving Elon Musk's platform X after the 2024 election, Bluesky, a decentralized social media alternative backed by Jack Dorsey, experienced a massive influx, reaching 15 mi...
By Newsweek | 1 week ago -
Webster OKs project that will bring 'extreme value' supermarket to town
Grocery Outlet Bargain Market received approval to open a new store in Webster Plaza, 980 Ridge Road. The store, known for offering discounted groceries, will occupy a vacant space next to Savers thri...
By Yahoo! Finance | 1 week ago
